News updates
-
18 SEP
Highlighting challenges in monitoring herbal products and presenting universal recommendations
Lareb conducted a study comprised of semi-structured interviews in order to explore the current ...
-
27 JUN
Prolonged duration of COVID-19 vaccine-induced lymphadenopathy
The Netherlands Pharmacovigilance Centre Lareb has received reports of enlarged lymph nodes after COVID-19 vaccination that do n...
-
30 MAY
Possible ischaemic colitis after bisacodyl use
The Netherlands Pharmacovigilance Centre Lareb received two reports of ischaemic colitis after bisacodyl use. Ischaemic colitis often resolves s...
-
28 MAY
Anaphylactic reaction to the complex of rocuronium and sugammadex
The sugammadex-rocuronium complex can cause severe allergic reactions. Also in patients who are not allergic to one of the in...
-
15 MAY
Agnes Kant appointed as professor at Leiden University
Epidemiologist and director of the Netherlands Pharmacovigilance Centre Lareb, Agnes Kant, has been appointed as professor in pharmacovi...
-
19 APR
Multi-national European cohort event monitoring studies on COVID-19 vaccines
Published results from the multi-national European cohort event monitoring show that most participants experience ...
-
23 JAN
More research needed into Long COVID-like adverse events after COVID-19 vaccination
The Netherlands Pharmacovigilance Centre Lareb has received reports of a combination of adverse events simi...
-
19 DEC
Sudden Sensorineural Hearing Loss and COVID-19 vaccines
Until January 10th 2023, the Netherlands Pharmacovigilance Centre Lareb received 109 reports of Sudden Sensorineural Hearing Loss (SSN...
-
08 DEC
Side effects of Tea Tree Oil
The World Health Organization (WHO) received 159 reports of complaints associated with the use of tea tree oil products. Skin complaints such as rash, hypersens...